window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : February 3, 2026

  • News
  • About Us
Contact Us

drug safety

  • Biologics & Biosimilars,Cell & Gene Therapy,Clinical Development,Drug Development,Rare Diseases,Research & Development

    iXCells Biotechnologies partners with Rosebud Biosciences to advance organoid models for rare diseases

    iXCells Biotechnologies and Rosebud Biosciences have announced a partnership to [...]

    January 29, 2026
  • Artificial Intelligence,Clinical Development,Pharmacovigilance,Regulatory Affairs,Research & Development

    Pistoia Alliance expands into pharmacovigilance space with launch of two new initiatives

    Collaboration efforts aim to reduce manual burden of adverse event [...]

    July 22, 2025
  • Clinical Development,Drug Development,Regulatory Affairs,Research & Development,Technology and platforms

    FDA’s phase-out of mandatory animal testing: Certara’s Patrick Smith on biosimulation and the future of drug development

    The US Food and Drug Administration’s (FDA) decision to phase [...]

    July 22, 2025
  • CDMOs & Manufacturing,Drug Delivery & Formulation,Regulatory Affairs,Technology and platforms

    $200M market in sight as Nutriband and Kindeva scale up abuse-deterrent fentanyl patch

    Milestone achieved for Aversa Fentanyl, a transdermal patch combining proven [...]

    June 24, 2025
  • Artificial Intelligence,Biologics & Biosimilars,Clinical Trials,Regulatory Affairs

    FDA shifts drug testing paradigm with plan to replace animal studies in monoclonal antibody development

    Regulators back AI and organ-on-a-chip technologies to modernize safety evaluation [...]

    June 24, 2025
  • Drug Development

    CN Bio expands liver-on-a-chip platform to include cross-species DILI models, enhancing IVIVE insights

    CN Bio has introduced two new animal-derived liver-on-a-chip models to [...]

    June 10, 2025
  • Clinical Trials,Drug Development,Partnerships & Funding,Technology and platforms

    Elsevier expands database with ClinicalTrials.gov to support drug and device development

    Elsevier has announced the addition of over 500,000 clinical trial [...]

    May 8, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Skyhawk Therapeutics reports positive nine-month interim results for SKY-0515 in Huntington’s disease
    Categories: Central Nervous System, Clinical Trials, Drug Development, Rare Diseases, Research & Development
  • iOrganBio appoints Karol Jarzabek as chief operating officer
    Categories: Biologics & Biosimilars, Cell & Gene Therapy, Healthcare leadership, Manufacturing, Movers & Shakers, Pharmaceuticals and therapeutics
  • iXCells Biotechnologies partners with Rosebud Biosciences to advance organoid models for rare diseases
    Categories: Biologics & Biosimilars, Cell & Gene Therapy, Clinical Development, Drug Development, Rare Diseases, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top